LeMaitre Vascular Inc (LMAT) stock
LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$76.10−0.91 (-1.18%)
Close on Nov 17, 2026Market cap $1.74BP/E 26.7Yield 1.05%
LeMaitre Vascular price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
LeMaitre Vascular's price to sales ratio was 6.9× on Nov 11, 2026, against 8.0× a year earlier. Over the last 5 years it ranged from 5.9× to 11.4×, with a median of 8.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 6.9× | −0.9 |
| 2025 | Dec 31, 2025 | 7.8× | −2.0 |
| 2024 | Dec 31, 2024 | 9.8× | +3.0 |
| 2023 | Dec 29, 2023 | 6.8× | +0.5 |
| 2022 | Dec 30, 2022 | 6.4× | −0.6 |
| 2021 | Dec 31, 2021 | 6.9× | +0.2 |
| 2020 | Dec 31, 2020 | 6.8× | +0.5 |
| 2019 | Dec 31, 2019 | 6.3× | +1.7 |
| 2018 | Dec 31, 2018 | 4.6× | −1.8 |
| 2017 | Dec 29, 2017 | 6.5× | +0.9 |
| 2016 | Dec 30, 2016 | 5.6× | +1.5 |
| 2015 | Dec 31, 2015 | 4.1× | +2.3 |
| 2014 | Dec 31, 2014 | 1.8× | −0.4 |
| 2013 | Dec 31, 2013 | 2.2× | +0.6 |
| 2012 | Dec 31, 2012 | 1.6× | −0.0 |
| 2011 | Dec 30, 2011 | 1.6× | −0.5 |
| 2010 | Dec 31, 2010 | 2.1× | – |
See a number that looks wrong?